The 2016 SRS Acquiom Life Sciences M&A Earnout Achievement Update presents almost a decade’s worth of experience managing over 100 deals with more than $27 billion in potential milestone payments. By now, over 200 separate milestones have become due, 10 times that described in our seminal 2012 Life Sciences M&A Study. Key data is presented on the percentages of milestones paid, including by sub-industry and development phase, as well as on earnout disputes, renegotiations, and best practices for managing these deals post-closing.

Related Stories